COPB2 and infection: Studies have shown that the expression of COPB2 in circulating EVs is substantially higher in patients with a mild infection symptom than in patients with a severe infection, suggesting that the expression of COPB2 in circulating EVs may be used as a predictor of disease regression (Fujita et al., 2021).